SG11201603343QA - Lung cancer diagnosis - Google Patents

Lung cancer diagnosis

Info

Publication number
SG11201603343QA
SG11201603343QA SG11201603343QA SG11201603343QA SG11201603343QA SG 11201603343Q A SG11201603343Q A SG 11201603343QA SG 11201603343Q A SG11201603343Q A SG 11201603343QA SG 11201603343Q A SG11201603343Q A SG 11201603343QA SG 11201603343Q A SG11201603343Q A SG 11201603343QA
Authority
SG
Singapore
Prior art keywords
lung cancer
cancer diagnosis
diagnosis
lung
cancer
Prior art date
Application number
SG11201603343QA
Inventor
Irmgard Irminger-Finger
Maxime Pilyugin
Pierre-Alain Andre
Original Assignee
Bard1Ag Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bard1Ag Sa filed Critical Bard1Ag Sa
Publication of SG11201603343QA publication Critical patent/SG11201603343QA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57423Specifically defined cancers of lung
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11201603343QA 2013-11-06 2014-11-05 Lung cancer diagnosis SG11201603343QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20130191739 EP2871480A1 (en) 2013-11-06 2013-11-06 Lung Cancer Diagnosis
PCT/EP2014/073834 WO2015067666A1 (en) 2013-11-06 2014-11-05 Lung cancer diagnosis

Publications (1)

Publication Number Publication Date
SG11201603343QA true SG11201603343QA (en) 2016-05-30

Family

ID=49518831

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201603343QA SG11201603343QA (en) 2013-11-06 2014-11-05 Lung cancer diagnosis

Country Status (10)

Country Link
US (1) US11137402B2 (en)
EP (2) EP2871480A1 (en)
JP (1) JP6698537B2 (en)
KR (1) KR102245621B1 (en)
CN (1) CN106062562B (en)
AU (1) AU2014345613B2 (en)
CA (1) CA2929457C (en)
IL (1) IL245477B (en)
SG (1) SG11201603343QA (en)
WO (1) WO2015067666A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10538556B2 (en) * 2016-11-07 2020-01-21 Colorado State University Research Foundation Anti-HIV peptides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4586697A (en) 1996-09-20 1998-04-14 Board Of Regents, The University Of Texas System Compositions and methods comprising bard1 and other brca1 binding proteins
FR2813606B1 (en) * 2000-09-01 2004-04-30 Inst Nat Sante Rech Med TRUNKED PROTEIN BARD1, AND ITS DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
JP2008048733A (en) * 2006-07-27 2008-03-06 Okayama Univ Method for forecasting crisis risk of cancer
EP2155900A1 (en) 2007-04-02 2010-02-24 Hopitaux Universitaires De Geneve Deletion bearing bard1 isoforms and use thereof
CN106153944B (en) 2010-08-17 2018-09-28 日内瓦大学 BARD1 isoforms, its detection method in lung cancer and colorectal cancer and its application
EP2619218B1 (en) * 2010-09-24 2020-04-29 BARD1 Life Sciences Limited Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof

Also Published As

Publication number Publication date
WO2015067666A1 (en) 2015-05-14
US11137402B2 (en) 2021-10-05
CA2929457C (en) 2022-09-20
IL245477A0 (en) 2016-06-30
JP6698537B2 (en) 2020-05-27
AU2014345613A1 (en) 2016-05-19
JP2016536622A (en) 2016-11-24
KR20160102979A (en) 2016-08-31
CN106062562A (en) 2016-10-26
EP2871480A1 (en) 2015-05-13
KR102245621B1 (en) 2021-04-29
AU2014345613B2 (en) 2020-07-09
CA2929457A1 (en) 2015-05-14
EP3066473A1 (en) 2016-09-14
US20160282347A1 (en) 2016-09-29
IL245477B (en) 2019-12-31
CN106062562B (en) 2021-11-30

Similar Documents

Publication Publication Date Title
AU351520S (en) Inhaler
GB201322725D0 (en) Cancer therapy
EP2950702A4 (en) Endoscope
EP2896352A4 (en) Endoscope
AU352076S (en) Inhaler
HUE038547T2 (en) Inhaler
EP2837324A4 (en) Endoscope
HK1220900A1 (en) Cancer therapy
PL2978481T3 (en) Inhaler
SG11201507847UA (en) Cancer therapy
PT3632373T (en) Inhaler
EP2870909A4 (en) Endoscope
EP2942002A4 (en) Endoscope
PL3035886T3 (en) Inhaler
ZA201508680B (en) Inhaler
EP2948769A4 (en) Platelet biomarkers in cancer diagnosis
EP2961412A4 (en) Cancer therapy
EP2881032A4 (en) Endoscope
EP3069139A4 (en) Bacterial diagnosis
EP2878254A4 (en) Endoscope
GB201302036D0 (en) Diagnosis
EP2893865A4 (en) Endoscope
IL245477B (en) Lung cancer diagnosis
GB201317213D0 (en) Cancer Therapy